Norwegian Omega 3

Product Rating: 
0
SKU: 4129
$39.99

 

Applications for Health Improvement

  • Supports cardiovascular health
  • Supports healthy mental functioning
  • Supports healthy glucose and insulin metabolism
  • Supports an anti-inflammatory response
  • Affects the production of arachidonic acid-derived eicosanoids​
  • Supports optimal joint function

 

120 Softgels

 

Our Omega 3 Fish Oils are International Fish Oil Standards (IFOS) five-star certified, which assures the highest level of purity, stability and potency in fish oils. EPA and DHA from fish oil promote wellness by supporting cardiovascular health, cytokine balance, joint health and brain and nervous system function.

Health Benefits of EPA/DHA: Research and studies have shown that omega-3 fatty acids antagonize arachidonic acid-induced eicosanoid formation; help generate resolvins and protectins to aid the body’s “cleanup” response to the arachidonic acid cascade; promote neurological health and mental functioning; and promote cardiovascular health, a balanced immune response, and healthy glucose and insulin metabolism [1-7]. Research suggests that it takes 2 g/day of DHA supplementation over a period of a month to saturate the plasma and three to six months of supplementation to saturate the tissues [8]. Concentrations of DHA increased in breast milk within less than a week of supplementation [8]. Resolvins and protectins are recently identified molecules that are generated from omega-3 polyunsaturated fatty acids (PUFA) precursors, which can orchestrate the timely resolution of inflammation in model systems.

GRAS-Certified Enteric Coating: Employs a fish-gelatin—not a bovine-gelatin softgel that is enteric-coated. The enteric coating helps ensure the fish oils reach the small intestine before being metabolized, resulting in better delivery of actives to the intestines for absorption. This delivery may also reduce the occurrence of a fishy aftertaste.

IFOS Five-Star Certified: Ensures purity and quality are paramount when selecting fish oil supplements. IFOS is the only third-party testing and certification program for omega-3 fish oil products; it sets the gold standard for analyzing products for comparison to the highest industry standards with regard to contaminants, stability, heavy metals, and potency. Furthermore, IFOS provides detailed results for all testing categories for each individual lot tested.

Processing: To achieve the level of quality found in our Norwegian Omega 3’s, a series of critical steps are undertaken: (1) raw fish oil triglycerides are broken down into ethyl esters; (2) EPA and DHA are separated from other fats and concentrated through flash distillation; (3) cold extraction further concentrates the oil, resulting in up to 85% omega-3; (4) molecular distillation removes fishy odor and taste, resulting in extremely fresh oil; (5) PCBs, chlorinated organopollutants and toxic heavy metals are removed through filtration; and (6) high purity products are packaged in 190 kg drums or 900 kg totes under inert gas.

 

References

  1. Storey A, McArdle F, Friedmann PS, et al. Eicosapentaenoic acid and docosahexaenoic acid reduce UVB- and TNF alpha-induced IL-8 secretion in keratinocytes and UVB-induced IL-8 in fibrolasts. J Invest Dermatol. 2005 Jan;124(1):248-55. [PMID: 15654981]
  2. Kim YJ, Kim HJ, No JK, et al. Anti-inflammatory action of dietary fish oil and calorie restriction. Life Sci. 2006 Apr 18;78(21):2523-32. [PMID: 16438990]
  3. Weylandt KH, Chiu CY, Gomolka B, et al. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 2012 Mar;97(3-4):73- 82. [PMID: 22326554]
  4. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomized double-blind placebo-controlled study. Br J Psychiatry. 2006 Jan;188:46-50. [PMID: 16388069]
  5. Ebbesson SO, Risica PM, Ebbesson LO, et al. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int J Circumpolar Health. 2005 Sep:64(4):396-408. [PMID:16277123]
  6. . Weitz D, Weintraub H, Fisher E, et al. Fish oil for the treatment of cardiovascular disease. Cardiol Rev. 2010 Sep-Oct;18(5):258-63. [PMID: 20699674]
  7. . Sasaki J, Yokoyama M, Matsuzaki M, et al. Relationship between coronary artery disease and non-HDL-C, and effect of highly purified EPA on the risk of coronary artery disease in hypercholesterolemic patients treated with statins: sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). J Atheroscler Thromb. 2012;19(2):194- 204. [PMID: 22186099]
  8. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1467S-1476S. Review. [PMID: 16841856]